 |
EUBioEar
|
|
|
MED EL Elektromedizinische Geräte, Innsbruck, Austria. Drug delivery Group. The role of the department within the programme will be to provide the cochlear implant/drug delivery systems for human trials and for other in-vivo investigations. MED EL is the largest cochlear implant company in Europe, and currently more than 5000 patients worldwide use MED EL devices. It has carried a number of implant and electrode designs through to approval by European and other regulatory authorities. It s electrode is designed specifically to do minimum damage to the cochlear structures upon implantation. For implant-related developments the company houses a large research team including implant development, mechanical construction, testing, documentation, and regulatory specialists. It maintains strong academic links with the University of Innsbruck, and has enjoyed successful collaborations with a number of basic and clinical research institutions. The company founding members (Dr Doz Hochmair and Prof Hochmair) have over 25 years of experience of cochlear implant design and manufacture: 1977 First hybrid cochlear implant worldwide (University of Vienna). 1980-1989 Collaboration with 3M. 1989 Foundation of MED EL 1994 The COMBI 40 system introduced 2001 FDA Approval gained for the Combi 40+ cochlear implant 2002 Next generation cochlear implant targeted.
Key Personnel
|
|
|
